MORGAN STANLEY - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$811,391
-21.7%
78,244
+8.1%
0.00%
Q2 2023$1,036,511
+54.9%
72,382
-22.7%
0.00%
Q1 2023$669,003
-13.8%
93,698
+35.4%
0.00%
Q4 2022$776,290
-24.3%
69,188
-25.1%
0.00%
Q3 2022$1,025,000
+11.5%
92,430
-15.1%
0.00%
Q2 2022$919,000
-20.2%
108,862
+28.7%
0.00%
Q1 2022$1,151,000
-58.0%
84,600
-39.2%
0.00%
Q4 2021$2,738,000
+219.5%
139,168
+420.6%
0.00%
Q3 2021$857,000
-4.4%
26,733
+0.9%
0.00%
Q2 2021$896,000
+44700.0%
26,492
+44801.7%
0.00%
Q1 2021$2,000
-99.2%
59
-99.3%
0.00%
Q4 2020$264,000
+560.0%
7,933
+624.5%
0.00%
Q3 2020$40,000
-63.6%
1,095
-67.1%
0.00%
Q2 2020$110,000
+423.8%
3,332
+300.5%
0.00%
Q1 2020$21,000
-95.3%
832
-94.2%
0.00%
Q4 2019$450,00014,4410.00%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 2,067,861$77,669,00045.24%
FRAZIER MANAGEMENT LLC 5,827,415$218,878,00017.56%
Abingworth LLP 1,203,135$45,057,00015.56%
Greenspring Associates, LLC 360,939$13,557,00010.78%
Penn Mutual Asset Management, LLC 86,940$3,265,0003.69%
RA Capital Management 3,115,008$117,000,0001.76%
Rhenman & Partners Asset Management AB 175,000$6,573,0000.46%
Summit Rock Advisors, LP 34,100$1,281,0000.44%
Eventide Asset Management 600,000$22,536,0000.33%
Parkman Healthcare Partners LLC 30,207$1,135,0000.26%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders